Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) Upgraded to Hold at Zacks Investment Research – Riverton Roll
Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) Upgraded to Hold at Zacks Investment Research Riverton Roll
Source: Investment New Feed